Stock TIGER X MEDICAL INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Tiger X Medical Inc Other OTC

Equities

US88677A1043

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Tiger X Medical Inc
May. 01 BioCardia, Inc. Announces the Primary Endpoint Results of the Open Label Roll-In Cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial CI
Apr. 30 Transcript : BioCardia, Inc. - Special Call

Chart calendar Tiger X Medical Inc

30a9c98b592dfa1a9131463e5162a.3Bm3wqn5PJJrOEFVcIXEGGwgLpbdIjX-fNVjfguzIc0.sW_eheSzc6EoDDYPJ9SCcDV2Z-K8ZgOrRIRTOSb0U4SSK8b7kZpxvw4AEA~bcd20dd97bb72d17433c2d98fd31df82

Upcoming events on Tiger X Medical Inc

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-05-19 Annual General Meeting
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-31 Q4 2024 Earnings Release (Projected)

Past events on Tiger X Medical Inc

2024-04-30 03:00 pm Business Update Call
2024-03-27 04:30 pm Q4 2023 Earnings Call
2024-03-27 04:00 pm Q4 2023 Earnings Release
2024-03-03 Technology and Heart Failure Therapeutics Conference
2023-11-08 04:30 pm Q3 2023 Earnings Call
2023-11-08 04:11 pm Q3 2023 Earnings Release
2023-10-18 12:00 pm Annual General Meeting
2023-08-09 04:30 pm Q2 2023 Earnings Call
2023-08-09 04:05 pm Q2 2023 Earnings Release
2023-07-11 Data Safety Monitoring Board Meeting
2023-05-10 04:30 pm Q1 2023 Earnings Call
2023-05-10 04:05 pm Q1 2023 Earnings Release
2023-03-29 04:30 pm Q4 2022 Earnings Call
2023-03-29 08:15 am Q4 2022 Earnings Release
2022-11-09 04:30 pm Q3 2022 Earnings Call
2022-11-09 04:05 pm Q3 2022 Earnings Release
2022-10-24 LD Micro Main Event XV
2022-10-05 08:55 am Heart Failure Society of America Meeting
2022-09-14 Cantor Fitzgerald Cell & Gene Therapy Conference
2022-09-11 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,71
0,57
25.44%		0,15
0,12
20.83%		1,02
0,77
31.87%		1,35
1,39
-2.45%		0,48
0,70
-31.86%
0,70

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-12,6
-11,5
-9.3%		-11,8
-12,9
8.38%		-11,6
-13,2
12.42%
-16,0

EBIT
Million USD		Released
Forecast
Spread 		-14,2
-14,5
1.75%		-15,5
-15,9
2.37%		-12,6
-13,7
7.95%		-11,9
-12,6
5.76%		-11,6
-13,2
11.79%
-16,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-14,7
-15,0
1.92%		-15,0
-16,0
6.32%		-12,6
-14,1
10.35%		-11,9
-12,9
7.7%		-11,6
-13,1
11.67%
-15,7

Net income
Million USD		Released
Forecast
Spread 		-14,7
-15,0
1.92%		-15,0
-15,9
5.57%		-12,6
-13,6
7.5%		-11,9
-12,6
5.68%		-11,6
-13,1
11.67%
-15,7

EPS
USD		Released
Forecast
Spread 		-2,61
-2,75
5.09%		-1,48
-1,57
5.93%		-0,75
-0,77
2.6%		-0,67
-0,72
6.29%		-0,55
-0,46
-19.57%
-0,42

Announcement Date09/04/2030/03/2129/03/2229/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,08
0,03
163.33%		0,06
0,19
-68.42%		0,97
0,07
1311.59%		0,21
0,11
87.61%		0,11
0,15
-30.72%		0,06
0,34
-81.18%		0,04
0,18
-76.57%		0,36
0,04
827.27%		0,01
0,19
-93.16%
EBITDA
Million USD		Released
Forecast
Spread 		-3,45
-2,40
-43.58%		-3,31
-3,00
-10.37%		-2,48
-3,50
29.14%		-3,03
-3,60
15.81%		-3,00
-4,00
25.08%		-3,49
-2,90
-20.28%		-3,43
-3,40
-0.91%		-2,58
-4,00
35.58%		-2,06
-3,60
42.67%
EBIT
Million USD		Released
Forecast
Spread 		-3,46
-4,82
28.17%		-3,33
-2,73
-21.82%		-2,50
-5,00
50.04%		-3,06
-4,03
24.12%		-3,02
-3,47
13.13%


-3,45
-3,53
2.07%		-2,60
-3,73
30.26%		-2,08


Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-3,46
-4,11
15.69%		-3,33
-2,81
-18.14%		-2,50
-4,95
49.59%		-3,06
-3,99
23.39%		-3,03
-4,00
24.3%		-3,50
-2,70
-29.67%		-3,42
-3,40
-0.71%		-2,57
-4,00
35.65%		-2,07
-3,60
42.44%
Net income
Million USD		Released
Forecast
Spread 		-3,46
-3,94
12.22%		-3,33
-2,81
-18.14%		-2,50
-4,57
45.36%		-3,06
-3,92
22.07%		-3,03
-3,73
18.92%		-3,50
-2,70
-29.67%		-3,42
-3,46
1.04%		-2,57
-4,00
35.65%		-2,07
-3,60
42.44%
EPS
USD		Released
Forecast
Spread 		-0,21
-0,19
-8.62%		-0,19
-0,18
-5.56%		-0,14
-0,26
45.1%		-0,17
-0,22
22.73%		-0,16
-0,21
21.95%		-0,17
-0,18
2.86%		-0,17
-0,17
0%		-0,12
-0,11
-9.09%		-0,09
-0,10
10%
Announcement Date29/03/2211/05/2210/08/2209/11/2229/03/2310/05/2309/08/2308/11/2327/03/24

Upcoming sector events for Tiger X Medical Inc

2024-05-05 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-05 KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
2024-05-05 MERUS N.V.: Q1 2024 Earnings Release (Projected)
2024-05-05 VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
2024-05-05 INHIBRX, INC.: Q1 2024 Earnings Release (Projected)
2024-05-05 BIONTECH SE: Q1 2024 Earnings Release
2024-05-06 07:00 am BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-06 04:01 pm VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
2024-05-06 COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-05-06 LYELL IMMUNOPHARMA, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Tiger X Medical Inc

2024-05-02 04:05 pm KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
2024-05-02 04:05 pm ZYMEWORKS INC.: Q1 2024 Earnings Release
2024-05-02 04:02 pm ARDELYX, INC.: Q1 2024 Earnings Release
2024-05-02 04:01 pm LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-02 04:01 pm ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
2024-05-02 04:00 pm ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
2024-05-02 11:00 am GENMAB A/S: Q1 2024 Earnings Release
2024-05-02 07:00 am GERON CORPORATION: Q1 2024 Earnings Release
2024-05-02 07:00 am AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-02 07:00 am BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. BCDA Stock
  4. Stock
  5. Calendar Tiger X Medical Inc